The Richard D. Frisbee III Laboratory of Stem Cell Transplantation and Hematopoietic Graft Engineering, a newly completed facility serving both the School of Medicine and Yale-New Haven Hospital, will be formally dedicated this week.
The laboratory is named in memory of Richard D. Frisbee, a child who received the first bone marrow transplant in the state. He was the son of former Yale Cancer Center stem cell administrator Christine Frisbee.
There will be an official dedication and open house at the new facility on Wednesday, Oct. 14, 4-6 p.m., beginning in conference room CB401 at Yale-New Haven Hospital. The public is invited.
The laboratory, made possible by a gift from the Frisbee Foundation, is a Class 10,000 clean room facility located within the department of laboratory medicine in the Blood Bank at Yale-New Haven Hospital. A Class 10, 000 facility provides an environment having less than 10,000 dust and other particles per cubic foot of air. It is suitable for performing the delicate stem cell, gene therapy and graft engineering manipulations needed for treating pediatric and adult cancer patients.
The laboratory will provide a needed research environment for investigators at the cutting edge of cancer therapy and will be a resource for clinical and basic science research shared by the departments of laboratory medicine, internal medicine, pediatrics, obstetrics and gynecology, and pathology at both the hospital and medical school, as well as the Yale Cancer Center.
Frisbee Symposium. The First Annual Frisbee Foundation Stem Cell Symposium will be held 8 a.m.-5 p.m. Thursday, Oct. 15, at the Omni New Haven Hotel at Yale, 155 Temple St.
The one-day symposium is designed to educate health-care professionals about clinical and molecular advances in blood and marrow transplants. Speakers will cover many of the new advances in blood stem cell transplantation, followed by a discussion of the role of stem cell therapy in treating leukemia. Participants also will discuss the latest advances in cord blood processing and how this will affect the future of stem cell transplantations; the latest advances in breast cancer research and options for the treatment of non-malignant disease by peripheral blood stem cells; the treatment of multiple myeloma using peripheral blood stem cell therapy; and the distinction between graft versus host disease.
The registration fee, which includes continental breakfast and lunch, is $75 for physicians and $50 for all other allied health professionals.
For more information about the symposium or open house, call Dr. Edward Snyder, blood bank director, at (203) 688-2441, or e-mail him at edward.snyder@yale.edu.